Private Market View

Synchron

New York, NY · Founded 2016 · Privately Held (backing)

PA Mark · $/share
$45
Sep 2026
Implied valuation
$385.0M
Total raised
$339.9M
Last round
Early Stage VC
Nov 2022

Key facts

as of Sep 2026
  • Synchron’s last known valuation is $385.0M (Dec 2022).
  • It has raised $339.9M across 1 recorded rounds; the latest was Early Stage VC ($49.9M) in Nov 2022.
  • Notable investors include Alumni Ventures, Khosla Ventures, United States Department of War, National Institutes of Health, In-Q-Tel — 47 tracked in total.
  • Private Market View tracks 11 recorded secondary trades in Synchron shares.
  • 4 investment vehicles were formed to buy Synchron shares in the last 12 months, reporting $6.8M sold to 158 investors, per SEC Form D filings.
  • Synchron has filed 1 Form D with the SEC, most recently Dec 2022 ($49.9M sold to 22 investors).
  • Status: Privately Held (backing).
PA Mark — composite indicative price
LOW confidence
~$45per share
as of Sep 2026 · the exact daily mark is a member feature
Composed from 5 inputs:3rd-party trades 100%
See the platform prints behind this mark →
Free account
See the evidence behind this price
  • ·Post-money valuations for all 1 rounds
  • ·The complete investor list — 47 names
  • ·Watchlist + deal alerts for Synchron
Create free account
No card required

Recorded secondary trades

11 on record · Oct 2025 – Jun 2026

11 trades between Oct 2025 and Jun 2026. Exact dates, prices and structures are available to Pro members.

Oct 2025peak 4 prints / monthJun 2026
Counts and months are public. The prints are the product.Unlock 11 trade prints

Institutional fund marks

No fund marks yet

No SEC-registered fund has reported a fair-value mark on Synchron in its N-PORT filings yet. We sweep new filings monthly.

Pro members can request priority coverage with a 48-hour turnaround.

Funding rounds

1 rounds
Nov 2022Early Stage VC$49.9MSEC filing▮
Full funding history →

Secondary demand: investment vehicles

from SEC Form D filings

In the last 12 months, 4 investment vehicles were formed to buy Synchron shares, reporting $6.8M sold to 158 investors across 4 sponsors. Most recent filing May 2026. Vehicles like these are how secondary buyers pool demand for a name; a rising count is a demand signal.

The vehicle list — each sponsor, filing date, amount sold and investor count — is a Pro table. Unlock the 4 vehicles →
Companies with the most vehicle activity →

About Synchron

Developer of an implantable stent-rode designed to create a brain-computer interface. The company offers a minimally invasive implantable device embedded with electrode arrays that interpret signals from the brain to modulate neural activity in specific regions, enabling patients with motor impairments to regain some level of control over digital devices, prosthetics, or other assistive technologies using their thoughts.

Sector
Healthcare
HQ
New York, NY, United States
Founded
2016
Employees
127
Ownership
Privately Held (backing)